164 related articles for article (PubMed ID: 37794471)
1. Development and validation of a new risk assessment model for immunomodulatory drug-associated venous thrombosis among Chinese patients with multiple myeloma.
Li X; Sun X; Fang B; Leng Y; Sun F; Wang Y; Wang Q; Jin J; Yang M; Xu B; Fang Z; Chen L; Chen Z; Yang Q; Zhang K; Ye Y; Geng H; Sun Z; Hao D; Huang H; Wang X; Jing H; Ma L; Pan X; Chen W; Li J
Thromb J; 2023 Oct; 21(1):105. PubMed ID: 37794471
[TBL] [Abstract][Full Text] [Related]
2. Derivation and Validation of a Risk Assessment Model for Immunomodulatory Drug-Associated Thrombosis Among Patients With Multiple Myeloma.
Li A; Wu Q; Luo S; Warnick GS; Zakai NA; Libby EN; Gage BF; Garcia DA; Lyman GH; Sanfilippo KM
J Natl Compr Canc Netw; 2019 Jul; 17(7):840-847. PubMed ID: 31319391
[TBL] [Abstract][Full Text] [Related]
3. Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score.
Sanfilippo KM; Luo S; Wang TF; Fiala M; Schoen M; Wildes TM; Mikhael J; Kuderer NM; Calverley DC; Keller J; Thomas T; Carson KR; Gage BF
Am J Hematol; 2019 Nov; 94(11):1176-1184. PubMed ID: 31379000
[TBL] [Abstract][Full Text] [Related]
4. External validation of the SAVED score for venous thromboembolism risk stratification in patients with multiple myeloma receiving immunomodulatory drugs.
Dima D; Li A; Granat LM; Dhillon P; Chamseddine F; Yalamanchali A; Mirzai S; Wei W; Samaras CJ; Valent J; Anwer F; Khouri J
Br J Haematol; 2023 Apr; 201(2):280-284. PubMed ID: 36604838
[TBL] [Abstract][Full Text] [Related]
5. Comparison of three risk assessment models for thromboembolism in multiple myeloma patients receiving immunomodulators: a Brazilian historical cohort.
da Costa IHF; de Pádua CAM; de Miranda Drummond PL; Silveira LP; Malta JS; Dos Santos RMM; Reis AMM
J Thromb Thrombolysis; 2023 Jul; 56(1):147-155. PubMed ID: 37133703
[TBL] [Abstract][Full Text] [Related]
6. A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study.
Gerotziafas GT; Taher A; Abdel-Razeq H; AboElnazar E; Spyropoulos AC; El Shemmari S; Larsen AK; Elalamy I;
Oncologist; 2017 Oct; 22(10):1222-1231. PubMed ID: 28550032
[TBL] [Abstract][Full Text] [Related]
7. [Multiple myeloma and venous thrombosis. Which thromboprophylaxis should be given?].
de Moreuil C; Ianotto JC; Eveillard JR; Carrier M; Delluc A
Rev Med Interne; 2016 Jul; 37(7):473-9. PubMed ID: 26833146
[TBL] [Abstract][Full Text] [Related]
8. Mitigating the risk of venous thromboembolism in patients with multiple myeloma receiving immunomodulatory-based therapy.
Covut F; Sanfilippo KM
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):363-367. PubMed ID: 36485142
[TBL] [Abstract][Full Text] [Related]
9. Derivation and External Validation of a Risk Assessment Model of Venous Thromboembolism in Hospitalized Chinese Patients.
Chen X; Huang J; Liu J; Chang J; Pan L; Wang Y; Gao Y; Yang Y
Clin Appl Thromb Hemost; 2023; 29():10760296221151164. PubMed ID: 36650933
[TBL] [Abstract][Full Text] [Related]
10. MELISSE, a large multicentric observational study to determine risk factors of venous thromboembolism in patients with multiple myeloma treated with immunomodulatory drugs.
Leleu X; Rodon P; Hulin C; Daley L; Dauriac C; Hacini M; Decaux O; Eisemann JC; Fitoussi O; Lioure B; Voillat L; Slama B; Al Jijakli A; Benramdane R; Chaleteix C; Costello R; Thyss A; Mathiot C; Boyle E; Maloisel F; Stoppa AM; Kolb B; Michallet M; Lamblin A; Natta P; Facon T; Elalamy I; Fermand JP; Moreau P
Thromb Haemost; 2013 Oct; 110(4):844-51. PubMed ID: 23903204
[TBL] [Abstract][Full Text] [Related]
11. Abnormal metaphase cytogenetics predicts venous thromboembolism in myeloma: derivation and validation of the PRISM score.
Chakraborty R; Rybicki L; Wei W; Valent J; Faiman BM; Samaras CJ; Anwer F; Khorana AA
Blood; 2022 Dec; 140(23):2443-2450. PubMed ID: 35772005
[TBL] [Abstract][Full Text] [Related]
12. Real-life practices for preventing venous thromboembolism in multiple myeloma patients: a cohort study from the French health insurance database.
Palmaro A; Rougé-Bugat ME; Gauthier M; Despas F; Moulis G; Lapeyre-Mestre M
Pharmacoepidemiol Drug Saf; 2017 May; 26(5):578-586. PubMed ID: 28198064
[TBL] [Abstract][Full Text] [Related]
13. Assessing the risk of venous thromboembolism in multiple myeloma.
Sanfilippo KM
Thromb Res; 2020 Jul; 191 Suppl 1():S74-S78. PubMed ID: 32736783
[TBL] [Abstract][Full Text] [Related]
14. Derivation, validation and assessment of a novel nomogram-based risk assessment model for venous thromboembolism in hospitalized patients with lung cancer: A retrospective case control study.
Li H; Tian Y; Niu H; He L; Cao G; Zhang C; Kaiweisierkezi K; Luo Q
Front Oncol; 2022; 12():988287. PubMed ID: 36300098
[TBL] [Abstract][Full Text] [Related]
15. Derivation and validation of a simple model to identify venous thromboembolism risk in medical patients.
Woller SC; Stevens SM; Jones JP; Lloyd JF; Evans RS; Aston VT; Elliott CG
Am J Med; 2011 Oct; 124(10):947-954.e2. PubMed ID: 21962315
[TBL] [Abstract][Full Text] [Related]
16. Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case-Control Studies.
Nemeth B; van Adrichem RA; van Hylckama Vlieg A; Bucciarelli P; Martinelli I; Baglin T; Rosendaal FR; le Cessie S; Cannegieter SC
PLoS Med; 2015 Nov; 12(11):e1001899; discussion e1001899. PubMed ID: 26554832
[TBL] [Abstract][Full Text] [Related]
17. External validation of the simplified Geneva risk assessment model for hospital-associated venous thromboembolism in the Padua cohort.
Blondon M; Righini M; Nendaz M; Glauser F; Robert-Ebadi H; Prandoni P; Barbar S
J Thromb Haemost; 2020 Mar; 18(3):676-680. PubMed ID: 31782886
[TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism (VTE) risk stratification in general medical patients at an academic medical center.
Fritz MK; Kincaid SE; Sargent CG; Green AH; Davis GA
J Thromb Thrombolysis; 2021 Jan; 51(1):67-73. PubMed ID: 32447745
[TBL] [Abstract][Full Text] [Related]
19. Incidence and risk assessment of venous thromboembolism in cancer patients admitted to intensive care unit for postoperative care.
Xu JX; Dong J; Ren H; Chen XJ; Yang Y; Chen RX; Wang GD; Wang HZ
J BUON; 2018; 23(1):500-506. PubMed ID: 29745099
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism in multiple myeloma - choice of prophylaxis, role of direct oral anticoagulants and special considerations.
Swan D; Rocci A; Bradbury C; Thachil J
Br J Haematol; 2018 Nov; 183(4):538-556. PubMed ID: 30450656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
